JPRN-UMIN000014679已完成3 期
Multi-institutional clinical test of TCD-14139 - Multi-institutional clinical test of TCD-14139
TERUMO CORPORATIO0 个研究点目标入组 27 人开始时间: 2014年7月28日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)(2)SAH in the last 60 days or intracranial hemorrhage in the last 30 days(3)Intracranial mass or currently undergoing radiation therapy for carcinoma or sarcoma of the head or neck region.(4)Symptomatic extracranial or intracranial stenosis of the parent artery(>50%) proximal to the target aneurysm;(5)Irreversible bleeding disorder.(6)Current alcohol or substance abuse.(7)uncontrolled severe hypertension >180 mm Hg or>115 mmHg,(8)cre 3.0mg/dL;(9)Hypersensitivity to metal, such as nickel-titanium and metal jewelry. (10)(11)Subject with contraindications or known allergies to anticoagulants or antiplatelets (aspirin, heparin, ticlopidine, clopidogrel, prasugrel or ticagrelor);Subject with documented contrast allergy, or other condition, that prohibits imaging.(12)Evidence of active infection at the time of treatment;(13)Presence of any of the unequivocal cardiac sources of embolism; (14)Intracranial stenting procedure associated with the target aneurysm; (15)Cerebral diagnostic angiogram that demonstrates an aneurysm that is not appropriate for endovascular treatment;(16)Subject has extracranial stenosis greater than 50% in the carotid artery of the targetaneurysm.(17)Subject has intracranial stenosis greater than 50% in the treated vessel(18)Subject has a mycotic or dissecting aneurysm.(19)Subject has a bifurcation.(20)Subject has a posterior circulation aneurysm.(21)Subjects aneurysm has significant branch exiting from dome of aneurysm.(22)Subject is harboring more than one aneurysm with both aneurysms requiring treatment at the same time.(23)Subject has an AVM in the area of the target aneurysm.
研究者
相似试验
已完成
3 期
Multi-institutional domestic clinical test of TCD-15152Subjects with a target carotid stenosis (more than 50% stenosis if symptomatic or more than 80% stenosis if asymptomatic) located CCA or ICA.JPRN-UMIN000023562TERUMO CORPORATIO140
已完成
不适用
Multicenter Study of TCD-11091 (Phase III Clinical Study)Patients with primary rectal cancer who are scheduled to undergo loop ileostomy during laparotomyJPRN-UMIN000010356Terumo Corporation124
已完成
不适用
Multi-institutional comparative test of TRM-108Patients requiring a postoperative Total Parenteral Nutrition.JPRN-UMIN000008478terumo corporation110
招募中
不适用
Multicenter Study of TCD-51073(E) (Feasibility Study)Severe heart failure due to chronic ischemic heart diseaseJPRN-UMIN000029824Terumo Corporation6
招募中
Unknown
Multicenter Study to Evaluate the Usefulness of TCR Repertoire as a Prognostic Marker in Postoperative Adjuvant Atezolizumab for Non-Small Cell Lung Cancernon-small cell lung cancerJPRN-jRCT1021230030Suzuki Hiroyuki20